HMGB1 and neoplasm: In the case of radiotherapy and other DNA damage treatments, the induction of immunogenic cell death will promote the release of tumor antigens and DAMPs such as high mobility group box 1 (HMGB1) and adenosine triphosphate (ATP), triggering the innate immune reaction.